engages in the design, manufacture, and distribution of micro-manufacturing systems consisting of compact robotic devices or automated devices, and companion sterile single-use disposables that are used to produce products sourced from single units of blood.
These biological products include hematopoietic stem cells for bone marrow rescue transplants and blood-derived proteins to assist surgeons in arresting bleeding or gluing tissues.
The company’s products for blood banks include BioArchive System, which enbles the processing, cryopreservation, and archiving of blood components units; BioArchive Accessories and Disposables that include overwrap bags, sealers, expressors, a manual retrieval device, canisters, processing bags, and freezing bags; ThermoLine Ultra-Rapid Plasma Thawers, used for thawing stored red blood cells or fresh frozen plasma before their transfusion; and Ultra-Rapid Plasma Freezers that optimize plasma freezing.
Its products for hospitals and wound care centers include CryoSeal Fibrin Sealant System that produces and dispenses a two-component fibrinogen and fibronectin protein sealant for surgical hemostasis and tissue adhesives; and thrombin processing device, which selects activated thrombin from blood plasma.
The company markets and sells its products through direct sales force and independent distributors to hospitals and blood banks located in the United States, Europe, Japan, Asia-Pacific, Canada, and Latin America.
The company has strategic alliances with Asahi Medical Co.
, Ltd.
; Dideco, S.
p.A.
; New York Blood Center; Air Water, Inc.; Pall Medical; and Nissho Corp.
ThermoGenesis was incorporated in Delaware in 1986 and is based in Rancho Cordova, California.
